These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 1295713)
1. The possible use of bisphosphonates in the treatment of renal osteodystrophy. Malluche HH Clin Nephrol; 1992; 38 Suppl 1():S87-91. PubMed ID: 1295713 [TBL] [Abstract][Full Text] [Related]
2. Calcium and phosphorus in diet therapy of uremia. Schoolwerth AC; Engle JE J Am Diet Assoc; 1975 May; 66(5):460-4. PubMed ID: 1123506 [TBL] [Abstract][Full Text] [Related]
3. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Lorenzo Sellares V; Torregrosa V Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742 [TBL] [Abstract][Full Text] [Related]
4. Analysis of renal bone disease treatment in dialysis patients. Johnson CA; McCarthy J; Bailie GR; Deane J; Smith S Am J Kidney Dis; 2002 Jun; 39(6):1270-7. PubMed ID: 12046041 [TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
7. Renal osteodystrophy in children with end-stage kidney failure. Chan JC Va Med; 1979 May; 106(5):384-90. PubMed ID: 463255 [TBL] [Abstract][Full Text] [Related]
8. Use and indication of vitamin D and vitamin D analogues in patients with renal bone disease. Malluche HH; Monier-Faugere MC; Koszewski NJ Nephrol Dial Transplant; 2002; 17 Suppl 10():6-9. PubMed ID: 12386263 [TBL] [Abstract][Full Text] [Related]
9. [Comparative clinical and histomorphological studies on the therapy of renal osteopathy using vitamin D and 5,6-trans-25-OHCC]. Schulz W; Heidler R; Gessler U; Offermann G; Schulz A; Delling G Verh Dtsch Ges Inn Med; 1975; 81():976-80. PubMed ID: 1229631 [No Abstract] [Full Text] [Related]
10. Osteodystrophy of dialysed patients treated with vitamin D. Verberckmoes R; Bouillon R; Krempien B Proc Eur Dial Transplant Assoc; 1973; 10(0):217-26. PubMed ID: 4370246 [No Abstract] [Full Text] [Related]
11. [Therapy of uremic osteodystrophy]. Fletti C; Docci D; Coli' L; Di Felice A G Clin Med; 1981 Apr; 62(4):270-9. PubMed ID: 7021295 [No Abstract] [Full Text] [Related]
13. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus. Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Johnson JR; George CR; Collett P; Kalowski S Q J Med; 1985 May; 55(217):127-44. PubMed ID: 4001311 [TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of uremic osteodystrophy. Agus ZS; Goldberg M Radiol Clin North Am; 1972 Dec; 10(3):545-56. PubMed ID: 4566892 [No Abstract] [Full Text] [Related]
15. [Effect of vitamin D metabolites on the markers of protein, calcium and phosphorus turnover in children with chronic renal failure]. Denisova SN; Kutafina EK; Sergeeva TV; Savina MI; Kon' IIa; Shilina NM; Chizhevskaia OL; Shilov AV Vopr Pitan; 1998; (1):14-7. PubMed ID: 9606860 [TBL] [Abstract][Full Text] [Related]
16. [Use of bisphosphonates in chronic kidney disease]. Torregrosa JV; Ramos AM Nefrologia; 2010; 30(3):288-96. PubMed ID: 20514097 [TBL] [Abstract][Full Text] [Related]
17. Can bisphosphonates play a role in the treatment of children with chronic kidney disease? Haffner D; Fischer DC Pediatr Nephrol; 2011 Dec; 26(12):2111-9. PubMed ID: 21267600 [TBL] [Abstract][Full Text] [Related]
18. Renal osteodystrophy and aging. Sherrard DJ Semin Nephrol; 2009 Nov; 29(6):636-42. PubMed ID: 20006795 [TBL] [Abstract][Full Text] [Related]
20. [Vitamin D in renal insufficiency--metabolism, hormonal forms, its effect and importance in the therapy of renal osteodystrophy]. Labos I Med Arh; 1986; 40(3):101-4. PubMed ID: 3272310 [No Abstract] [Full Text] [Related] [Next] [New Search]